| Intangible Asset, Finite-Lived [Table Text Block] |
| | | Estimated | | | | | | | | | | | | | |
| | | Useful Life | | | Gross Carrying | | | Accumulated | | | Net Carrying | |
| | | ( Years) | | | Amount | | | Amortization | | | Value | |
| Amortized intangible assets: | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| Cardiac electrophysiology segment | | | | | | | | | | | | | | | | |
| Developed technology ‐ VIVO | | | 10 | | | $ | 170 | | | $ | (4 | ) | | $ | 166 | |
| Developed technology ‐ LockeT | | | 14 | | | | 18,770 | | | | (4,357 | ) | | | 14,413 | |
| Customer relationships | | | 6 | | | | 62 | | | | (34 | ) | | | 28 | |
| Trademarks/trade names ‐ VIVO | | | 10 | | | | 14 | | | | — | | | | 14 | |
| Trademarks/trade names ‐ LockeT | | | 9 | | | | 409 | | | | (148 | ) | | | 261 | |
| | | | | | | $ | 19,425 | | | $ | (4,543 | ) | | $ | 14,882 | |
| Private aviation segment | | | | | | | | | | | | | | | | |
| Licensing agreements/ vendor and supplier contracts | | | 5 | | | | 300 | | | | (4 | ) | | | 296 | |
| Applications | | | 5 | | | | 400 | | | | (6 | ) | | | 394 | |
| Technology | | | 10 | | | | 1,000 | | | | (7 | ) | | | 993 | |
| Trademarks/ trade names | | | 15 | | | | 1,250 | | | | (6 | ) | | | 1,244 | |
| Customer list/ relationships | | | 15 | | | | 3,000 | | | | (14 | ) | | | 2,986 | |
| | | | | | | $ | 5,950 | | | $ | (37 | ) | | $ | 5,913 | |
| | | | | | | $ | 25,375 | | | $ | (4,580 | ) | | $ | 20,795 | |
| Indefinite life intangible assets: | | | | | | | | | | | | | | | | |
| Private aviation segment | | | | | | | | | | | | | | | | |
| Goodwill | | | — | | | | 9,725 | | | | — | | | | 9,725 | |
| FAA Part 135 Operating Certificate | | | — | | | | 1,500 | | | | — | | | | 1,500 | |
| | | | | | | | | | | | | | | | | |
| Total | | | | | | $ | 36,600 | | | $ | (4,580 | ) | | $ | 32,020 | |
| | | Estimated | | | | | | | | | | | | | |
| | | Useful Life | | | Gross Carrying | | | Accumulated | | | Net Carrying | |
| | | ( Years) | | | Amount | | | Amortization | | | Value | |
| Amortized intangible assets: | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| Cardiac electrophysiology segment | | | | | | | | | | | | | | | | |
| Developed technology ‐ VIVO | | | 15 | | | $ | 170 | | | $ | — | | | $ | 170 | |
| Developed technology ‐ LockeT | | | 14 | | | | 18,770 | | | | (4,022 | ) | | | 14,748 | |
| Customer relationships | | | 6 | | | | 62 | | | | (31 | ) | | | 31 | |
| Trademarks/trade names ‐ VIVO | | | 9 | | | | 14 | | | | — | | | | 14 | |
| Trademarks/trade names ‐ LockeT | | | 9 | | | | 409 | | | | (136 | ) | | | 273 | |
| | | | | | | $ | 19,425 | | | $ | (4,189 | ) | | $ | 15,236 | |
|
| Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block] |
| | | Future | |
| | | Amortization | |
| Years ending December 31, | | Expense | |
| Remainder of 2026 | | $ | 1,454 | |
| 2027 | | | 1,938 | |
| 2028 | | | 1,938 | |
| 2029 | | | 1,928 | |
| 2030 | | | 1,928 | |
| Thereafter | | | 11,610 | |
| Total | | $ | 20,795 | |
|